To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Clinical trial NCT04566666 · COMPLETED
Trial details
- NCT number
- NCT04566666
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2024-11-20
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.